Medicus Pharma has received FDA clearance to begin a Phase [...]

EnteroBiotix has dosed the first patient in its Phase 2b [...]

As Rare Disease Day 2026 shines a spotlight on patients [...]

ViiV Healthcare, the global specialist HIV company majority owned by [...]

Cereno Scientific has completed the last patient’s last visit in [...]

MaaT Pharma has reported a positive outcome from the second [...]

Nektar Therapeutics has received FDA Fast Track designation for its [...]